Skip to content

A study to evaluate the effect of ginger in the management of Rheumatoid arthritis

"A Pharmaco-clinical Study Of Shunthi(Zingiber officinale Roxb) Churna in the Management of Amavata(Rheumatoid arthritis)"

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/04/008419
Enrollment
30
Registered
2017-04-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients who are suffering from Amavata (Rheumatoid Arthritis)

Interventions

Intervention1: SHUNTHI CHURNA: 2 gm/ day for 1 month Control Intervention1: Nil: Nil

Sponsors

Parul Institute Of Ayurved
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having classical signs and symptoms of Amavata will be selected for study

Exclusion criteria

Exclusion criteria: Systemic disorders like cardiac disease, DM,HTN, Cancer, Respiratory disease More than 10 years old disease Asadhya laxan of amavata

Design outcomes

Primary

MeasureTime frame
All the signs and symptoms of Amavata will be assigned score depending upone their severity to assess the effect of the drugs at the time of before treatment and after treatment.Timepoint: With time period of 30 days

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactMilan Jayantibhai Prajapati

Parul Institute Of Ayurved

drmilanprajapati@gmail.com9724575599

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026